Prestige Consumer Healthcare Inc
F:PBV
Prestige Consumer Healthcare Inc
F:PBV
Price:
56
EUR
2.75%
Market Closed
Market Cap:
€2.8B
Relative Value
The Relative Value of one
PBV
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 56 EUR,
Prestige Consumer Healthcare Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PBV Relative Value
HIDDEN
Multiples Across Competitors
PBV Competitors Multiples
Prestige Consumer Healthcare Inc Competitors
Prestige Consumer Healthcare Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Prestige Consumer Healthcare Inc
F:PBV
|
3.2B EUR | 2.9 | 15.8 | 11.1 | 12.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
983.7B USD | 15.1 | 47.7 | 32.1 | 34.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.8B USD | 6.2 | 21.9 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286.9B CHF | 4.7 | 30.6 | 12.9 | 15 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233.3B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
241.3B CHF | 5.5 | 22.2 | 13.7 | 17.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.3 | 9.7 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD | 2.5 | 20.2 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.7B USD | 2.6 | 17.5 | 6.8 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
